I can tell you from firsthand experience (as an investor) that the gist of this article is 100% correct: there are significant barriers to bringing a new medical device to market that have nothing to do with the merits of the product or the supply chain, but are quite simply pure protectionism for the established players. If anyone wants details, contact me privately.
How the medical supply industry blocks device startups from selling to hospitals
41–50 of 157 posts
Re: How the medical supply industry blocks device startups from selling to hospitals
#42Two guys found (and patented) a way to get rid of very expensive human (hospital) waste. Working product in a few hospitals and everything, but they're looking for a way to scale up (they are great hackers but suck at finding an investor). Any tips?
Re: How the medical supply industry blocks device startups from selling to hospitals
#43I'm glad that our startup isn't dealing with medical devices, only with software. Still, I've been working with some medical device makers and it is a wild and crazy world they work in. The whole GPO system is clearly broken, but I've met some people - at device makers no less - that are passionate about ending it. We're doing our part to help that along.
Can you be more specific about what you're doing? I'm in medical device and I would love to see software startups help untangle the mess that is healthcare reimbursement and purchasing.
I can't really be super specific yet publicly, but we may be able to talk further.
Re: How the medical supply industry blocks device startups from selling to hospitals
#44Someone needs to bring BYOD to the medical industry ;)
Then overnight pure capitalism would create an efficient market to import and distribute them. When it's cheaper to buy heroin on the street than an aspirin in a hospital you know that the market is screwed up somewhere
Re: How the medical supply industry blocks device startups from selling to hospitals
#45As an entrepreneur I have dedicated most of the last 25 years to doing hardware (read: manufacturing) ventures. Manufacturing in the US is hard, if not impossible, save cases where the ecosystem or nature of the market can support it. Problems one could face include: ip (patents) mine field, government regulations, liability issues, lack of localized supply chains, high labor costs, high insurance costs, high taxes a…
Very well put in general. We're avoiding the device angle as well, due to the same things you've mentioned.
Re: How the medical supply industry blocks device startups from selling to hospitals
#46Interesting bit from the end of the article: "This isn’t just bad news for Shaw. Because his company is in the red, he has been unable to pull together the financing he needs to expand his factory in Little Elm. So he has partnered with Chinese companies, which put up money to build assembly lines in China in return for permission to produce his syringes for the Chinese market. When his patents do run out, the Chines…
Re: How the medical supply industry blocks device startups from selling to hospitals
#47When I think of the federal government 'fixing' health care, this is the sort of thing I think they can fix. Not single payer, not mandatory coverage, just good enforcement of anti-competitive practices, ways to enable innovation with patient consent Etc.
Re: How the medical supply industry blocks device startups from selling to hospitals
#48As an entrepreneur I have dedicated most of the last 25 years to doing hardware (read: manufacturing) ventures. Manufacturing in the US is hard, if not impossible, save cases where the ecosystem or nature of the market can support it. Problems one could face include: ip (patents) mine field, government regulations, liability issues, lack of localized supply chains, high labor costs, high insurance costs, high taxes a…
http://www.stltoday.com/news/national/article_44747e48-649e-...
Re: How the medical supply industry blocks device startups from selling to hospitals
#49This was on my mind this morning because my girlfriend isn't rich and relies on Lunesta to sleep (I'll leave the fact that her doctor is advising her to take this indefinitely for another day). It's extortionately priced - something like $6 a pill - enough to gouge insurance companies thoroughly and enough to wreck havoc on the finances of someone that's not rich and lacks insurance.
It turns out, this is actually the most profitable drug in the world. Yet they can't even sell it in the EU because it's a modest derivative of a (generic) drug that's been around since 1989.
It's disturbing that this is where the patent game ends - with power-brokering and lawyering determining who gets the wealth and power.
Re: How the medical supply industry blocks device startups from selling to hospitals
#50Earlier quoted context omitted.
> I'm doubtful that a Kaiser spokesman would fabricate these problems, Why?
Because that's defamation.
Either way, it is not a direct argument with the statement.